Bullboard - Stock Discussion Forum SPDR Series Trust - SPDR S&P Biotech ETF XBI

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests... see more

Add To Watchlist

ARCA:XBI - Post Discussion

SPDR Series Trust - SPDR S&P Biotech ETF > FSD Pharma Inc: Lucid MS Video

View:

Post by GwenTracy on Apr 16, 2022 11:15am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

120